$ACTG
ACACIA RESEARCH CORP Stock $actg

$actg Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000093454923000054 Filed on May 11, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$7.904M	$14.80M
YoY Change	-52.72%	9.6%
Cost Of Revenue	$8.943M	$9.958M
YoY Change	-3.07%	11.31%
Gross Profit	-$1.039M	$4.845M
YoY Change	-113.87%	6.23%
Gross Profit Margin	-13.15%	32.73%
Selling, General & Admin	$11.29M	$13.95M
YoY Change	-13.3%	6.76%
% of Gross Profit		287.99%
Research & Development	$205.0K	$216.0K
YoY Change	41.38%	13.68%
% of Gross Profit		4.46%
Depreciation & Amortization	$3.408M	$3.381M
YoY Change	-49.71%	0.36%
% of Gross Profit		69.78%
Operating Expenses	$11.49M	$14.17M
YoY Change	-12.7%	6.86%
Operating Profit	-$12.53M	-$9.324M
YoY Change	120.97%	9.59%
Interest Expense	-$7.895M	$21.25M
YoY Change	-81.21%	-126.69%
% of Operating Profit
Other Income/Expense, Net	-$7.895M	$21.25M
YoY Change	-81.21%	-126.69%
Pretax Income	-$20.42M	$11.93M
YoY Change	-57.17%	-113.53%
Income Tax	-$1.645M	$2.483M
% Of Pretax Income		20.81%
Net Earnings	-$18.78M	$9.447M
YoY Change	-69.47%	-112.89%
Net Earnings / Revenue	-237.59%	63.82%
Basic Earnings Per Share	-$0.36	$0.12
Diluted Earnings Per Share	-$0.36	-$0.07
COMMON SHARES
Basic Shares Outstanding	58.55M shares	58.57M shares
Diluted Shares Outstanding	58.41M shares	89.07M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$444.8M	$461.7M
YoY Change	-5.19%	-19.37%
Cash & Equivalents	$355.2M	$364.2M
Short-Term Investments	$89.60M	$97.47M
Other Short-Term Assets	$20.73M	$20.10M
YoY Change	291.76%	305.14%
Inventory	$14.01M	$14.73M
Prepaid Expenses
Receivables	$6.267M	$8.666M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$485.8M	$505.2M
YoY Change	-2.87%	-15.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.950M	$3.275M
YoY Change	-24.03%	-15.7%
Goodwill	$7.541M	$7.541M
YoY Change	0.95%	0.95%
Intangibles	$30.59M	$33.62M
YoY Change	-28.4%	-26.52%
Long-Term Investments	$30.93M	$30.93M
YoY Change	-57.64%	0.0%
Other Assets	$6.925M	$5.359M
YoY Change	37.37%	1.63%
Total Long-Term Assets	$48.92M	$51.41M
YoY Change	-20.51%	-20.56%
TOTAL ASSETS
Total Short-Term Assets	$485.8M	$505.2M
Total Long-Term Assets	$48.92M	$51.41M
Total Assets	$534.7M	$556.6M
YoY Change	-4.81%	-15.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.789M	$8.413M
YoY Change	5.56%	58.8%
Accrued Expenses	$9.022M	$15.69M
YoY Change	-13.33%	-3.17%
Deferred Revenue	$1.022M	$1.206M
YoY Change	-25.83%	-17.0%
Short-Term Debt	$60.45M	$61.35M
YoY Change	-47.81%	-63.63%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$77.81M	$90.21M
YoY Change	-42.88%	-53.6%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.858M	$1.674M
YoY Change	74.3%	43.69%
Total Long-Term Liabilities	$1.858M	$1.674M
YoY Change	74.3%	43.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$77.81M	$90.21M
Total Long-Term Liabilities	$1.858M	$1.674M
Total Liabilities	$176.1M	$179.4M
YoY Change	-36.28%	-40.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$316.1M	-$297.3M
YoY Change	-0.12%	16.61%
Common Stock	$58.00K	$58.00K
YoY Change	41.46%	23.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$98.26M	$98.26M
YoY Change	13.23%	68.63%
Treasury Stock Shares
Shareholders Equity	$324.4M	$344.6M
YoY Change
Total Liabilities & Shareholders Equity	$534.7M	$556.6M
YoY Change	-4.81%	-15.85%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$18.78M	$9.447M
YoY Change	-69.47%	-112.89%
Depreciation, Depletion And Amortization	$3.408M	$3.381M
YoY Change	-49.71%	0.36%
Cash From Operating Activities	-$14.77M	-$4.349M
YoY Change	2.66%	37.5%
INVESTING ACTIVITIES
Capital Expenditures	$54.00K	$83.00K
YoY Change	-101.0%	144.12%
Acquisitions
YoY Change
Other Investing Activities	$6.489M	$2.866M
YoY Change	-91.23%	-71.24%
Cash From Investing Activities	$6.435M	$2.783M
YoY Change	-90.62%	-71.98%
FINANCING ACTIVITIES
Cash Dividend Paid		$700.0K
YoY Change		0.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-673.0K	$78.00M
YoY Change	-99.16%	-391.46%
NET CHANGE
Cash From Operating Activities	-14.77M	-$4.349M
Cash From Investing Activities	6.435M	$2.783M
Cash From Financing Activities	-673.0K	$78.00M
Net Change In Cash	-9.011M	$76.44M
YoY Change	-64.56%	-482.36%
FREE CASH FLOW
Cash From Operating Activities	-$14.77M	-$4.349M
Capital Expenditures	$54.00K	$83.00K
Free Cash Flow	-$14.83M	-$4.432M
YoY Change	64.49%	38.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000934549
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-37721
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Acacia Research Corporation
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4405754
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	767 Third Avenue,
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	6th Floor
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York,
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10017
CY2023Q1	dei	City Area Code CityAreaCode	332
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	236-8500
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2023Q1	dei	Trading Symbol TradingSymbol	ACTG
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	58551798	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	364227000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	287786000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	60724000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	61608000	usd
CY2023Q1	us-gaap	Trading Securities Debt TradingSecuritiesDebt	5816000	usd
CY2022Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	5816000	usd
CY2023Q1	actg	Equity Method Investments Current EquityMethodInvestmentsCurrent	30934000	usd
CY2022Q4	actg	Equity Method Investments Current EquityMethodInvestmentsCurrent	30934000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8666000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8231000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	14725000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	14222000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	20099000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19388000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	12694000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	505191000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	427985000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3275000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3537000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	7541000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	7541000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	33624000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	36658000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1614000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2005000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5359000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5202000	usd
CY2023Q1	us-gaap	Assets Assets	556604000	usd
CY2022Q4	us-gaap	Assets Assets	482928000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	8413000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6036000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	14058000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5490000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4737000	usd
CY2023Q1	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	1060000	usd
CY2022Q4	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	699000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1206000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1229000	usd
CY2023Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	61350000	usd
CY2022Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	60450000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	90213000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	87209000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	520000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	568000	usd
CY2023Q1	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	11812000	usd
CY2022Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	16835000	usd
CY2023Q1	actg	Embedded Derivative Fair Value Of Embedded Derivative Liability1 EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability1	73152000	usd
CY2022Q4	actg	Embedded Derivative Fair Value Of Embedded Derivative Liability1 EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability1	84780000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1566000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1873000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	502000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	742000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1674000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1675000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	179439000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	193682000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	21478000	usd
CY2022Q4	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	19924000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58551798	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58551798	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43484867	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43484867	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	58000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	43000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	16183703	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	98258000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	98258000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	740187000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	663284000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-297342000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-306789000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	344645000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	258280000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	11042000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	11042000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	355687000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	269322000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	556604000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	482928000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14803000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13507000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	216000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	190000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1913000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2016000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12040000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11053000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	24127000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	22015000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9324000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8508000	usd
CY2023Q1	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	3343000	usd
CY2022Q1	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	-172203000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	-1361000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	66876000	usd
CY2023Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	1982000	usd
CY2022Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-105327000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	16651000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	28098000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	80000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-813000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	900000	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2601000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3441000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1007000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	21254000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-79636000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11930000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-88144000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2483000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-14878000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	9447000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-73266000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	9447000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-73266000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5958000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-75117000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47971931	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46544313	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.61
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-6496000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-75117000	usd
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	89067821	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	46544313	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.61
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	269322000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	9447000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	1554000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	700000	usd
CY2023Q1	actg	Issuance Of Common Stock From The Rights Offering IssuanceOfCommonStockFromTheRightsOffering	79111000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	416000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	477000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	355687000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	430475000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-73266000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	1151000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	700000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1174000	usd
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	10988000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	345472000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	9447000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-73266000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3381000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3369000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	51000	usd
CY2023Q1	actg	Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative	5023000	usd
CY2022Q1	actg	Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative	3942000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	896000	usd
CY2023Q1	actg	Unrealized Gain Loss On Derivatives1 UnrealizedGainLossOnDerivatives1	11628000	usd
CY2022Q1	actg	Unrealized Gain Loss On Derivatives1 UnrealizedGainLossOnDerivatives1	23260000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	477000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1174000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	80000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-813000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	3343000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-172203000	usd
CY2023Q1	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-1361000	usd
CY2022Q1	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	66876000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-240000	usd
CY2022Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-15039000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	451000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-318000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	503000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1084000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	391000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1246000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2355000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4261000	usd
CY2023Q1	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	360000	usd
CY2022Q1	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	-161000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-71000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	418000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4349000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3163000	usd
CY2023Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	5166000	usd
CY2022Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	92877000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	8032000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	102842000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	83000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2783000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9931000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	10988000	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	usd
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	15000000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	700000	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	700000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	416000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	72000	usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	79111000	usd
CY2022Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	77995000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-26760000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	76441000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-19992000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	287786000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	309361000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	364227000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	289369000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	147000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2000	usd
CY2023Q1	actg	Patent Acquisition Accrued Liability Long Term PatentAcquisitionAccruedLiabilityLongTerm	6000000	usd
CY2022Q1	actg	Patent Acquisition Accrued Liability Long Term PatentAcquisitionAccruedLiabilityLongTerm	0	usd
CY2023Q1	actg	Number Of Patent Portfolios Acquired NumberOfPatentPortfoliosAcquired	0	patent
CY2021Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	2950000	gbp
CY2021Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	4000000	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	71000	usd
CY2022Q1	us-gaap	Interest Income Other InterestIncomeOther	78000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	760000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	59157000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	17922000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	16355000	usd
CY2023Q1	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	60724000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	63383000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	14819000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	16594000	usd
CY2022Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	61608000	usd
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2022Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	2096000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4335000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	5277000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	3045000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7773000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7340000	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	15146000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	14720000	usd
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	421000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	498000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	14725000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	14222000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5399000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5327000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2124000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1790000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3275000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3537000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	347000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	335000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	7541000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	7470000	usd
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	us-gaap	Goodwill Goodwill	7541000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	7541000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	343532000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	309908000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33624000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	343533000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	306875000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	36658000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3000000	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022Q1	actg	Accelerated Amortization Of Patents AcceleratedAmortizationOfPatents	0	usd
CY2023Q1	actg	Accelerated Amortization Of Patents AcceleratedAmortizationOfPatents	0	usd
CY2022Q4	actg	Accrued Consulting And Other Professional Fees AccruedConsultingAndOtherProfessionalFees	1173000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	2496000	usd
CY2022Q4	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	9300000	usd
CY2023Q1	actg	Recapitalization Agreement Blocker Provision Percent RecapitalizationAgreementBlockerProvisionPercent	0.0489
CY2022Q4	actg	Recapitalization Agreement Blocker Provision Percent RecapitalizationAgreementBlockerProvisionPercent	0.0489
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58543312	shares
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	9035000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	10692000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	8347000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2483000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1733000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1334000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33624000	usd
CY2023Q1	actg	Accrued Patent Investment Costs AccruedPatentInvestmentCosts	15000000	usd
CY2023Q1	actg	Accrued Patent Investment Costs Current AccruedPatentInvestmentCostsCurrent	6000000	usd
CY2022Q4	actg	Accrued Patent Investment Costs Current AccruedPatentInvestmentCostsCurrent	9000000	usd
CY2023Q1	actg	Accrued Patent Investment Costs Current Installment Amount AccruedPatentInvestmentCostsCurrentInstallmentAmount	3000000	usd
CY2023Q1	actg	Accrued Consulting And Other Professional Fees AccruedConsultingAndOtherProfessionalFees	1446000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	474000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	40000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	36000	usd
CY2023Q1	actg	Service Contract Costs Accrued Current ServiceContractCostsAccruedCurrent	253000	usd
CY2022Q4	actg	Service Contract Costs Accrued Current ServiceContractCostsAccruedCurrent	280000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1493000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1559000	usd
CY2023Q1	actg	Accrued Patent Investment Costs Current AccruedPatentInvestmentCostsCurrent	6000000	usd
CY2022Q4	actg	Accrued Patent Investment Costs Current AccruedPatentInvestmentCostsCurrent	9000000	usd
CY2023Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	966000	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1536000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	12694000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	14058000	usd
CY2022Q1	actg	Debt Instrument Required Minimum Amount Held In Escrow DebtInstrumentRequiredMinimumAmountHeldInEscrow	35000000	usd
CY2021Q4	actg	Debt Instrument Required Minimum Amount Held In Escrow DebtInstrumentRequiredMinimumAmountHeldInEscrow	35000000	usd
CY2023Q1	actg	Recapitalization Agreement Blocker Provision Percent RecapitalizationAgreementBlockerProvisionPercent	0.0489
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58543312	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20000000	shares
CY2023Q1	actg	Common Stock Percentage Of Shares Outstanding CommonStockPercentageOfSharesOutstanding	0.342
CY2023Q1	us-gaap	Legal Fees LegalFees	0	usd
CY2021Q4	us-gaap	Legal Fees LegalFees	36000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	388000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	293000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1157000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1140000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	457000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	239000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	66000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3059000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1493000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1566000	usd
CY2022Q1	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	1151000	usd
CY2022Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	3125819	shares
CY2022Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	40000000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P1Y
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2023Q1	actg	Ownership Percent Of Voting Stock OwnershipPercentOfVotingStock	0.10
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	243319	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	199000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	243319	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.10
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	209000	usd
CY2023Q1	us-gaap	Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Basic UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic	1235000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	6000000	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y3M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1	P5Y
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	9447000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-73266000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	700000	usd
CY2022Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	700000	usd
CY2023Q1	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	1554000	usd
CY2022Q1	us-gaap	Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Basic UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic	0	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5958000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-75117000	usd
CY2023Q1	actg	Dividend On Series A Redeemable Convertible Preferred Stock DividendOnSeriesARedeemableConvertiblePreferredStock	700000	usd
CY2022Q1	actg	Dividend On Series A Redeemable Convertible Preferred Stock DividendOnSeriesARedeemableConvertiblePreferredStock	0	usd
CY2023Q1	actg	Accretion Of Series A Redeemable Convertible Preferred Stock AccretionOfSeriesARedeemableConvertiblePreferredStock	1554000	usd
CY2022Q1	actg	Accretion Of Series A Redeemable Convertible Preferred Stock AccretionOfSeriesARedeemableConvertiblePreferredStock	0	usd
CY2023Q1	actg	Change In Fair Value Of Series A Redeemable Convertible Preferred Stock Embedded Derivative ChangeInFairValueOfSeriesARedeemableConvertiblePreferredStockEmbeddedDerivative	5023000	usd
CY2022Q1	actg	Change In Fair Value Of Series A Redeemable Convertible Preferred Stock Embedded Derivative ChangeInFairValueOfSeriesARedeemableConvertiblePreferredStockEmbeddedDerivative	0	usd
CY2023Q1	actg	Change In Fair Value Of Series A Warrants ChangeInFairValueOfSeriesAWarrants	0	usd
CY2022Q1	actg	Change In Fair Value Of Series A Warrants ChangeInFairValueOfSeriesAWarrants	0	usd
CY2023Q1	actg	Change In Fair Value Of Dilutive Series B Warrants ChangeInFairValueOfDilutiveSeriesBWarrants	11628000	usd
CY2022Q1	actg	Change In Fair Value Of Dilutive Series B Warrants ChangeInFairValueOfDilutiveSeriesBWarrants	0	usd
CY2023Q1	actg	Interest Expense Associated With Starboard Notes Net Of Tax InterestExpenseAssociatedWithStarboardNotesNetOfTax	708000	usd
CY2022Q1	actg	Interest Expense Associated With Starboard Notes Net Of Tax InterestExpenseAssociatedWithStarboardNotesNetOfTax	0	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	1235000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	4845000	usd
CY2022Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	usd
CY2022Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-6496000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-75117000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47971931	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46544313	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89067821	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46544313	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.61
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.61
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2368870	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	109029318	shares
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14803000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13507000	usd
CY2023Q1	us-gaap	Royalty Expense RoyaltyExpense	221000	usd
CY2022Q1	us-gaap	Royalty Expense RoyaltyExpense	170000	usd
CY2023Q1	actg	Contingent Legal Fees ContingentLegalFees	532000	usd
CY2022Q1	actg	Contingent Legal Fees ContingentLegalFees	549000	usd
CY2023Q1	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	1384000	usd
CY2022Q1	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	1244000	usd
CY2023Q1	actg	Amortization Of Patents AmortizationOfPatents	2601000	usd
CY2022Q1	actg	Amortization Of Patents AmortizationOfPatents	2601000	usd
CY2023Q1	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	5220000	usd
CY2022Q1	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	4192000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	9958000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	8756000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	4751000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9324000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8508000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	21254000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-79636000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11930000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-88144000	usd
CY2023Q1	actg	Trading Securities Fair Value Disclosure TradingSecuritiesFairValueDisclosure	60724000	usd
CY2022Q4	actg	Trading Securities Fair Value Disclosure TradingSecuritiesFairValueDisclosure	61608000	usd
CY2023Q1	us-gaap	Trading Securities Debt TradingSecuritiesDebt	5816000	usd
CY2022Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	5816000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	30934000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	30934000	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	97474000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	98358000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	235144000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	156394000	usd
CY2023Q1	us-gaap	Assets Assets	556604000	usd
CY2022Q4	us-gaap	Assets Assets	482928000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14803000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13507000	usd
CY2023Q1	us-gaap	Noncurrent Assets NoncurrentAssets	3275000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	3537000	usd

Files In Submission

Name	View Source	Status
actg-20230331_cal.xml	Edgar Link	unprocessable
actg-20230331_def.xml	Edgar Link	unprocessable
0000934549-23-000054-index-headers.html	Edgar Link	pending
0000934549-23-000054-index.html	Edgar Link	pending
0000934549-23-000054.txt	Edgar Link	pending
0000934549-23-000054-xbrl.zip	Edgar Link	pending
actg-20230331.htm	Edgar Link	pending
actg-20230331.xsd	Edgar Link	pending
actg-20230331xex311.htm	Edgar Link	pending
actg-20230331xex312.htm	Edgar Link	pending
actg-20230331xex321.htm	Edgar Link	pending
actg-20230331xex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
actg-20230331_lab.xml	Edgar Link	unprocessable
actg-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
actg-20230331_htm.xml	Edgar Link	completed
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACTG
ACACIA RESEARCH CORP Stock $actg

2023 Q2 Form 10-Q Financial Statement

#000093454923000054 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG ACACIA RESEARCH CORP Stock $actg

2023 Q2 Form 10-Q Financial Statement

#000093454923000054 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG
ACACIA RESEARCH CORP Stock $actg